Abstract | BACKGROUND:
VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome) is a recently described syndrome caused by a somatic missense variant at the methionine-41 (p.(Met41)) position in the ubiquitin-like modifier activating enzyme 1 (UBA1) in Xp11.3. Germline pathogenic variants in UBA1 are associated with a distinct phenotype: a syndrome with severe neurologic features associated with loss of anterior horn cells and infantile death denominated X-Linked Spinal Muscular Atrophy 2 ( SMAX2) (OMIM 301,830). CASE PRESENTATION: We report a male individual with the phenotype of VEXAS syndrome that was initially identified through exome sequencing (ES) as having a hemizygous germline variant in UBA1 due to high variant allele frequency (VAF). Research Sanger sequencing was able to confirm the absence of the p.(Met41Val) variant in a skin biopsy and in gastric mucosa tissue sample confirming the variant happened as a postzygotic event. CONCLUSIONS: The present case exemplifies the diagnostic challenge that was imposed by the high VAF detected by ES that failed to correctly demonstrate that the variant was in a mosaic state. Sequencing of different tissues should be considered when there is conflict between the UBA1 variant status and the clinical findings.
|
Authors | Matheus V M B Wilke, Eva Morava-Kozicz, Matthew J Koster, Christopher T Schmitz, Shannon Kaye Foster, Mrinal Patnaik, Kenneth J Warrington, Eric W Klee, Filippo Pinto E Vairo |
Journal | BMC rheumatology
(BMC Rheumatol)
Vol. 6
Issue 1
Pg. 54
(Aug 30 2022)
ISSN: 2520-1026 [Electronic] England |
PMID | 36038944
(Publication Type: Journal Article)
|
Copyright | © 2022. The Author(s). |